For more information please visit www.boehringer-ingelheim.com.
References:
1 Kessler R, White LA, Birnbaum H, et al. Impact of Depression and its
Pathways on Work Productivity. Presented at the American Psychiatric
Association 160th Annual Meeting, San Diego, 21 May 2007
2 World Health Organization. Factsheet - Depression, 2005. Available at:
http://www.who.int/mental_health/managem....
Last visited 26 April 2007
3 Murray CJL, Lopez AD, eds. The Global Burden of Disease; 1996.
4 American Psychiatric Association. Diagnostic and Statistical Manual of
Mental Disorders. 4th ed., Text Revision. Washington DC: American
Psychiatric Association; 2000:345-428.
5 Ormel J, et al. Common mental disorders and disability across cultures:
results from the WHO Collaborative Study on Psychological Problems in
General Health Care. JAMA. 1994;272:1741-1748.
6 Spitzer RL, et al. Utility of a new procedure for diagnosing mental
disorders in primary care: the PRIME-MD 1000 study. JAMA.
1994;272:1749-1756.
7 Ormel J, Koeter MWJ, van den Brink W, van de Willige G. Recognition,
management, and course of anxiety and depression in general practice.
Arch Gen Psychiatry. 1991;48:700-706.
8 Simon GE et al. An International Study of the Relation Between Somatic
Symptoms and Depression. New Engl J Med. 1999;341(18):1329-35.
9 Paykel ES, et al. Psychol Med. 1995;25(6):1171-1180.
O--LLY
Web site: http://www.boehringer-ingelheim.com
David J. Shaffer of Eli Lilly and Company, +1-317-651-3710; or Ute E. Schmidt of Boehringer Ingelheim, +49-6132-77-97296